A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of EPIEFFECT When ...
Patients with radiologically staged T3-4, N0-2, M0 colon cancer were randomly allocated (2:1) to 6 weeks oxaliplatin-fluoropyrimidine preoperatively plus 18 postoperatively (NAC group) or 24 weeks ...
University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder ...
Medical Technologies announced today that its sensory insoles, analytics platform, and remote monitoring program will be used in a new clinical trial funded by the National Institutes of Health (NIH).
Background Guidelines strongly recommend reperfusion therapy, including thrombolysis and percutaneous coronary intervention, ...
Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today shared promising results from the ...
Group announced the publication of interim results from its CAMPAIGN trial, a randomized controlled trial designed to evaluate the ...
MedPage Today on MSN
Rapid-Acting Drug for Major Heart Attacks Hits Main Goal in Trial
NEW ORLEANS -- Patients experiencing major heart attacks had a lower risk of serious complications if they received a single ...
Black and Hispanic individuals with obesity appear underrepresented in GLP-1 weight loss trials, compared with the overall ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback